chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from consumer, for the Pregnancy Registry for VARIVAX (Oka/Merck), concerning a 34 year old female who in January 2007, was vaccinated with the first dose of VARIVAX (Oka/Merck) and a booster in February 2007 and then she got pregnant 3 months after that. When after the pregnancy the physician did a titer test to check if she built up the immunity for the vaccine it came out as non detectible (0.474 ADIGG and 0.5ABIGM). The patient went ahead and got another VARIVAX vaccine (Oka/Merck) dose a week ago (approximately 07-OCT-2008). There was no concomitant medication. The patient sought medical attention. Additional information has been requested.
Information has been received from a physician concerning an 18 year old female, who on 17-MAR-2008 was vaccinated with a first dose of GARDASIL, the patient was noted to be very nervous. Concomitant therapy included antimicrobials (unspecified) for acne. Subsequently, a couple days post vaccination the patient developed a herpes outbreak around her mouth and claimed that she had never had any outbreaks prior to the vaccination. At the time of the report, the outcome of the patient was unknown. Additional information has been requested.
I experience extreme fatigue and body aches a few days after receiving the vaccine and had to go to the ER approximately a month after the fact because the symptoms did not subside in May. The ER doctors administered a Flu and COVID test since it was past the 48-hours. I was given antibiotics for the Flu and tested negative for COVID. The ER advised that I see my PCP and I scheduled an appointment where I was given a prescription for steroids and a Z-Pak. She advised me to rest upon returning home and I was able to do so after taking the medications
This spontaneous report was received from a nurse practitioner, a female patient of unknown age via the company representative reporting on herself. The patient's medical history included cold sores. The patient's concurrent conditions and concomitant medications were not reported. The patient reported that she used to get cold sores regularly but after receiving ZOSTAVAX (dose, route, lot # and expiration date unknown) about seven years ago (in approximately 2009), she stopped getting cold sores completely and the reporter believed that ZOSTAVAX was what kept cold sores away. The reporter mentioned that she believes that ZOSTAVAX efficacy must be lasting about seven years because of an unknown date in 2016 she had experienced cold sore for the first time in seven years after vaccination. The reporter thought that the efficacy of ZOSTAVAX had decreased after seven years and that is why she started to get cold sores again. The outcome of the events was unknown. Causality was not provided by the reporter. Additional information is not expected as the reporter did not provide consent to follow-up.
Pt had target lesions from head to toe, no involvement of mucus membranes, fever after 5 days greater than 101, no joint swelling but by 5th day pt was refusing to ambulate but could have been due to abscess and well as fever.
chills; fever; body aches; This case was reported by a consumer via call center representative and described the occurrence of chills in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st  dose received on an unknown date, the body ache resolved after about 3 days refer case US2021AMR259260).   On 15th December 2021, the patient received the 2nd dose of Shingrix (intramuscular). In December 2021, less than a week after receiving Shingrix, the patient experienced chills, fever and general body pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the chills, fever and general body pain were recovered/resolved.   It was unknown if the reporter considered the chills, fever and general body pain to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient's husband. Age at vaccination was not reported. The patient received 2nd Shingrix dose and she had fever, chills and body ache for almost 2 days.  The patient was now feeling better at the time of reporting. The reporter had nothing else to report. The patient was not available to provide consent for MD follow up. The reporter permission denied for follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR259260:same reporter
3-5 mins p/receiving DTP/Pedvax/OPV pt became quite pale & listless; pt required stimulation; pt cont these episodes for 2 hrs repeatedly; they lessened p/2 hrs; the last 1 was 24 hrs p/the shot;
Information has been received from a physician concerning a 26 year old female who on 23-JUL-2007 was vaccinated intramuscularly with her first dose of Gardasil (lot# 658100/0525U).  On 22-OCT-2007 the patient was vaccinated intramuscularly with her second dose of Gardasil (lot# 658556/1060U).  On 19-NOV-2007 the patient experienced an abnormal Pap with results of atypical squamous cells of undetermined significance.  The patient's abnormal Pap and atypical squamous cells of undetermined significance persisted. The patient sought medical attention in the office.  Additional information has been requested.
pt presents to ED with increasing hypoxia x 2 days, more lethargic; placed on BiPAP; positive test for COVID; given remdesivir, Tocilizumab, dexamethasone, ABX, O2 demands increased; pt was made comfort care; DNR; pt passed away in the hospital; DC and med records sent per VAERS request
This case was received from a health professional in the United States on 04 March 2008, and is one of a cluster of two cases. A three-month-old male patient received an intramuscular left leg injection of ACTHIB (lot number UF345AC, A0512) and an intramuscular right leg injection of IPOL (lot number A0474-2) on 03 March 2008. His parents called the physician's office five hours after vaccination to report constant crying, which they described as "screaming", and vomiting. Outcome was unknown. Follow-up information was received from the health professional on 25 June 2008. The patient's date of birth was reported as 16 November 2007. Date of administration was 15 February 2008, and the events occurred later the same day. On 14 January 2008, the patient had received first intramuscular thigh injections of TRIPEDIA (lot number U2291BA) and PREVNAR (Wyeth, lot number B54007H). No additional information was provided. The health professional who reported this case also reported a similar event for another three-month-old patient, this event is captured in case number 2008-00645.
Body temperature of 100.2, body aches, nausea, tiredness  These were not debilitating but were noticable symptoms. They lasted around 5 hours and were easily treated with ibuprofen
following morning child awoke with rash over back, chest, abdomen, progressed to arms, legs, bottom, and face/neck.  Treated with po pediatric BENADRYL.
Upper left are red, swollen, indurated and slightly itchy on day 12 after Moderna vaccine injection.  Some muscle pain in area.  Some generalized muscle aches.  No fever, no vomiting/diarrhea, no other rashes.
swollen, itchy eyes.  swollen, itchy hands.  slightly swollen lips.  hives.  haven't recovered as of 12/10/2009, 3:45 PM
4/1/15, Day of vaccine administered to day 3 states aware had sot. Severe pain started 4/4/15 upper arm, states above elbow to shoulder. States injection given top, proximal part of deltoid, not middle. Unable to use arm or sleep unless takes MOTRIN 4 tabs 2 x day. MOTRIN relieves pain. Heating pad. States had full R.O.M. denies numbness, swelling, redness. Refer to doctor. Denies lifting or injury to arm.
Patient's Blood Pressure  Emergency: 187/107. Pt was lightheaded and felt like she was going to pass out. Tested Blood pressure twice: 187/107, then 181/104. then administered 25 mg of Benadryl, waited 15 mins and took blood pressure again 167/88.
Received last set of shots last Thurs (Here) Friday 10:30AM his mom called said he was shaking. Took him to Medical ER. Diagnosed w/Febrile seizure. I took him home w/Ibuprofen/TYLENOL and kept fever controlled. Still has fever-cough/runny nose and irritability.
Breakthrough Covid, unknown variation on June 19, 2022. I have had all the boosters. I was tested by a health care professional on Monday, June 20. It was positive. I was retested on June 28, 2022. It was negative. We were quarantined for 10 days. Symptoms: Lack of taste and smell, Severe coughing, Fatigue. I took antivirals.
This case was reported by a consumer and described the occurrence of fatigue in a 50-year-old female subject who was vaccinated with HEPATITIS B VACCINE (manufacturer unspecified0. A physician or other health care professional has not verified this report. Concurrent medications included unknown concurrent medication (CQ10) and Omega-3 marine triglycerides (Omega 3 fish oil). On 7 December 2011 at 10:00 the subject received 3rd dose of HEPATITIS B VACCINE in the left arm. On 7 December 2011, within hours of vaccination with HEPATITIS B VACCINE (the symptoms presented the same afternoon following the morning vaccination), the subject experienced fatigue, headache, nausea and flu-like symptoms. At the time of reporting the events were unresolved. The subject reported that she was fine prior to vaccination with HEPATITIS B VACCINE. Follow up information received from the physician on 12 December 2011. Concurrent medical conditions included sulfa allergy and drug sensitivity ("known sensitive to medication in general"). The physician stated that the subject was not on any concomitant medications. Historic vaccination included ENGERIX B; GlaxoSmithKline: unknown route; given in 2007. The physician reported that the subject was vaccinated on 07 December 2011 with ENGERIX B (GlaxoSmithKline) and experienced flu-like symptoms. The physician considered the event as probably related to the ENGERIX B vaccine. The physician reported that she had never had a subject with flu-like symptoms that had "persisted this long". No further details was provided.
pt recv vax 8AUG96 & 18JUN97 pt devel 50 lesions, a fever & vomiting;
Baby held breath until she turned cyanotic and syncopal. After syncope, started breathing normally. (No seizure activity)
24 hours after immunization left deltoid, red, swollen 11.5 cm x 8 cm.  No fever, uses Aum fine.
PT ARE WAS RED AND SWOLLEN AT SITE OF ADMINISTRATION, PCP GAVE PT BACTRIM DS AND IBUPROFEN.
Weeks of heavy pins and needles in all arms and legs, feet, hands. Electric buzzing feeling in hands. Involuntary jerking of all limbs and muscle spasms in all limbs. Left side facial twitching. Heavy legs. Imbalance standing and walking. Startling awake with immediate hyper vigilant type feeling on awakening. Sleep disturbance. Aching large muscles. Very Painful tendons and joints. Extremely sensitive and painful feet.
Vasovagal reaction 7mins after vaccine administration Patient laid on the floor and water was provided At 4;47pm, patient felt much better, symptoms resolved Discharged to home
Patient called the pharmacy to report swelling and injection site reaction on the arm with the vaccines. Had patient check for temperature, which was 98.1 degrees Farenheit. Advised patient to put ice on the area to minimize swelling and rotate arm to minimize discomfort. Called patient 2 other times during the day to make sure she was doing well. Patient reporting doing better and feeling better.
1 week after injection, site of injection became raised, hot and very itchy.  Rash/ welt Area about 6? by 4?. Google is calling this Covid Arm? Treated with anti itch cream for 2 days. Improving..
COVID-19 treatment; COVID-19 treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Apr2021 as dose 1, single (Lot number: EW0151), in left arm, on 26Apr2021 as dose 2, single (Lot number: EW0165), in left arm and on 05Jan2022 as dose 3 (booster), single (Lot number: 3313013A) at the age of 49 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hashimoto thyroiditis" (unspecified if ongoing); "high bp" (unspecified if ongoing); "adult HSP that caused some kidney damage" (unspecified if ongoing); "adult HSP that caused some kidney damage" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; SYNTHROID; ZYRTEC [CETIRIZINE HYDROCHLORIDE].  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "COVID-19 treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Negative; (2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient was treated with Paxlovid from 25Jul2022 to 29Jul2022. Patient had no allergy. The patient received other medications/products within 2 weeks of starting COVID-19 treatment. patient previously receive a COVID-19 Vaccine. Device Date : 08Aug2022.
pain (left arm); This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 14-JUN-2023, the patient received Shingrix (left arm). On 14-JUN-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: pain (left arm)). The outcome of the pain in arm was not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     It was unknown if the company considered the pain in arm to be related to Shingrix.   Additional Information: GSK Receipt date: 14-JUN-2023 A reporter reported about her self she received her first dose of SHINGRIX today on the day of reporting. The patient stated that her left arm hurts. The reporter did not consent to follow up.
Information has been received from a physician referring to a patient of unknown age and gender. The patient's medical history, concomitant therapy and concurrent condition were not provided. On 01-AUG-2016, the patient was vaccinated with a dose of temperature excursion M-M-R II (dose, route, lot number and expiration date were unknown), which experienced temperature excursion. This is one of several reports from the same reporter. Additional information has been requested.
Headache, Fever, chills swelling, and discomfort to injection site Narrative:
autoimmune disease caused by the vaccine; still got sick; Initial information received on 10-Jan-2022 from United states regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves Adult and unknown demographic patient who had autoimmune disease caused by the vaccine and still got sick while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date the patient developed a serious autoimmune disease caused by the vaccine (autoimmune disorder) (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant. On an unknown date the patient developed a non-serious still got sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the events (autoimmune disease caused by the vaccine, still got sick).  At time of reporting, the outcome was Unknown for the event autoimmune disease caused by the vaccine and was Unknown for the event still got sick.
patient is 2.5 weeks post-op and has multiple (10-12) large pulmonary opacities concerning for organizing pneumonia (has no infectious symptoms, just developed back pain and mild difficulty taking deep breaths)
stomach cramps; daily bouts of diarrhea; This is a spontaneous report from a contactable consumer (patient). This is one of two reports from same patient. A 65-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9261 and expiration date was not reported), via an unspecified route of administration, administered in Left arm on 21Jan2021 13:00 as single dose for covid-19 immunization. The patient received second dose of BNT162B2 (solution for injection: Lot number: EM9809), via an unspecified route of administration on 02Feb2021 at 01:15 pm on the left arm as a single dose for COVID-19 immunization. The patient medical history included osteoporosis, arthritis and allergies to crabmeat and wool. Concomitant medication included meloxicam 7.5 mg. The patient did not receive any vaccines 4 weeks prior to covid vaccination. The patient stated that, on 25Jan2021 (reported as 3 to 4 days after the first dose), she had 36 hours of stomach cramps, followed by ongoing daily bouts of diarrhoea. The patient stated that changes in diet did not help. The patient started to plan to call her doctor (today). The patient was not treated for the events. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Starting the day after vaccination painfully swollen lymph node under armpit on arm where shot was given. This lasted for 4 days. Felt flushed (warm skin but no fever) started day after vaccination and lasted 2 days. Fatigue the day following vaccination lasting for a day.
Patient was given vaccine injections in left deltoid, several minutes after she became pale. Placed in chair, patient passed out, was unresponsive for several minutes. BP 120/80  Pulse 88.
Broke out full body hives and itchiness, that has continued to this date. Doctor at hospital saw me and referred me to a dermatologist, and my own doctor has said this condition will last as long as histamine is in my system.  Where I am scratched/skin tested, there is an immediate reaction in the shape of the scratching.
Working diagnosis of Limbic encephalitis/NMDA-Ab encephalitis. 24 y/o male with no significant PMH. During p.m. of 22 JUL, while on the computer, patient had a sudden onset of twitching followed by generalized convulsions (witnessed). Patient remains hospitalized at clinic on 30 AUG 2013.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   Patient took Moderna vaccine on 11-Nov-2021 at 9.11 am. No concomitant information was reported. No treatment information was reported.
Initial report from a health care professional on 09 Aug 2010: This patient was vaccinated with MENVEO (batch number 100005), 0.5ml intramuscularly, on 13 Jul 2010. The reporter stated that patient was administered with partial dose of MENVEO (only MenCYW-135 liquid conjugate component). No adverse events were reported. Follow up report received health care professional on 27 Aug 2010: The patient potentially received a partial dose of MENVEO. It was reported that, they would send titers and based on results of titers they would determine full dose of patient.
"feels like I am having an autoimmune flare up, I feel so fatigued and crappy; "feels like I am having an autoimmune flare up, I feel so fatigued and crappy; "feels like I am having an autoimmune flare up, I feel so fatigued and crappy; "feels like I am having an autoimmune flare up, I feel so fatigued and crappy; cannot lift her head up; scared; This is a spontaneous report from a contactable consumer (patient). A 56-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Apr2021 as single dose for covid-19 immunisation. First dose was administered on 06Apr2021. Medical history included rheumatoid arthritis, ongoing Sjogren's, ongoing epilepsy, ongoing autoimmune disorder. The patient's concomitant medications were not reported. The patient experienced "feels like i am having an autoimmune flare up, i feel so fatigued and crappy'' on May2021, cannot lift her head up on May2021, scared on May2021. Her doctor prescribed a medrol dose pack to take orally, 4mg po. "I was suppose to take 6 of the pills last night and I only took 2 pills." Caller reported that sometimes the steroids helps with the fatigue from her autoimmune disorder and that is how her physician treats it. Caller reported that she started taking the Medrol Dosepack last night, 11May2021. Caller reported that she just took a couple because she was afraid to take all 6 tablets at once.  It has been 2 weeks since her 2nd vaccine. She has not had a flare up like this for 6 months. The events outcome was unknown.    Description of complaint: Caller reported that she doesn't know if the Pfizer Covid-19 vaccine works.  Caller reported that the Pfizer Covid-19 vaccine works for some people and it depends if you build up immunity.  Information on the lot/batch number has been requested
erythematous, firm, warm to touch, painful 6cm area lt deltoid; appear 5 days p/vax;
flu-like symptoms; fatigue; pain at the injection site; bled a lot after they gave him the injection; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection) (seriousness criterion medically significant). On 24-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at the injection site). At the time of the report, VACCINATION SITE HAEMORRHAGE (bled a lot after they gave him the injection), INFLUENZA LIKE ILLNESS (flu-like symptoms), FATIGUE (fatigue) and VACCINATION SITE PAIN (pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medications were not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.